TearSolutions Raises $3M Series A Round to Advance the Treatment of Dry Eye

TearSolutions LLC, a Charlottesville-based biotechnology company, has successfully closed its $3M Series A round with investments led by Santen Pharmaceuticals,...

Rivanna Medical recieves FDA clearance of its Accuro device

Rivanna Medical (CRCF FY2014 awardee, CRCF FY2013 awardee, and CIT GAP Funds portfolio company) announced today that it has received FDA 510(k) clearance...

CIT GAP Funds Invests in PockitShip

CIT announced today that its CIT GAP Funds has led a new round of investment in PockitShip, the Uber-like, on-demand pickup and delivery service targeting...


Who We Are:

CIT GAP Funds is a family of seed- and early-stage investment funds placing near-equity and equity investments in Virginia-based technology, life science, and cleantech companies.  CIT GAP Funds invests in companies with a high potential for achieving rapid growth and generating significant economic return for entrepreneurs, co-investors and the Commonwealth of Virginia.  CIT’s family of funds includes:

  • GAP Fund I – A vintage 2004 fund fully invested in a broad array of seed-stage technology companies. Portfolio.
  • GAP BioLife Fund – A seed fund investing exclusively in life science companies. 
  • GAP Tech Fund – A seed fund investing in IT and technology companies.
  • Commonwealth Energy Fund (CEF), a seed fund investing in energy efficiency and renewable energy companies. 

Follow CIT GAP Funds on: